Leukemia, 0887-6924
Journal
Publications
- Published
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
& 2 others, , 1 Apr 2010, In: Leukemia. 24, 4, p. 877-881 5 p.Research output: Contribution to journal › Article
- Published
A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL
Anna Skowronska, Tatjana Stankovic, 1 Jul 2008, In: Leukemia. 22, 7, p. 1456-1459 4 p.Research output: Contribution to journal › Article
- Published
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
Charlotte Bradbury, Farhat Khanim, McNeill Hayden, Christopher Bunce, Darren White, Mark Drayson, Charles Craddock & Bryan Turner, 25 Aug 2005, In: Leukemia. 19, 10, p. 1751-1759 9 p.Research output: Contribution to journal › Article
- Published
Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia
Aimee Jackson, Josephine Khan, Naeem Khan, Charles Craddock & Sylvie Freeman, Apr 2015, In: Leukemia. 29, p. 988-991Research output: Contribution to journal › Article › peer-review
- Published
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage
Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In: Leukemia. 26, 4, p. 826-830 5 p.Research output: Contribution to journal › Article
- Published
Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3
Christopher Bunce & Geoff Brown, 1 Jan 1994, In: Leukemia. 8, 4, p. 595-604 10 p.Research output: Contribution to journal › Article › peer-review
- Published
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: Results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
Robert Hills, Keith Wheatley, 1 Jan 2013, In: Leukemia. 27, 1, p. 75-81 7 p.Research output: Contribution to journal › Article › peer-review
- Published
The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
Keith Wheatley, 1 Jul 2011, In: Leukemia. 25, 7, p. 1122-1127 6 p.Research output: Contribution to journal › Article
- Published
A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
Sylvie Freeman, 31 Dec 2018, In: Leukemia. 5 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia
Robert Hills, Sylvie Freeman, 30 Sep 2016, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- Published
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells
Marwan Cheng Kuang Kwok, Nov 2005, In: Leukemia. 19, p. 1896-1904Research output: Contribution to journal › Article › peer-review
- Published
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party
Keith Wheatley, 2 May 2002, In: Leukemia. 16, 5, p. 776-784 9 p.Research output: Contribution to journal › Article
- Published
IMWG consensus on risk stratification in multiple myeloma
Keith Wheatley, Feb 2014, In: Leukemia. 28, 2, p. 269-77 9 p.Research output: Contribution to journal › Article › peer-review
- Published
MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
Stephanie Dumon, Sylvie Freeman, Ban Dawood, Lozan Sheriff, Maelle Lorvellec, Jon Frampton & Paloma Garcia, 2012, In: Leukemia. 27, 3, p. 661-670 10 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3
Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- Published
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL -r AML)
Charles Craddock, 2015, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- Published
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
Charles Craddock, Sylvie Freeman, Manoj Raghavan, Robert Hills, Toon Brookes, Mark Griffiths & 5 others, , 2012, In: Leukemia. 27, 5, p. 1028-1036 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.
Charles Craddock, 1 May 2011, In: Leukemia. 25, 5, p. 808-13 6 p.Research output: Contribution to journal › Article
- Published
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Sudhesh Kumar & Keith Wheatley, Sep 2009, In: Leukemia. 23, 9, p. 1545-56 12 p.Research output: Contribution to journal › Article › peer-review
- Published
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
& 15 others, , Feb 2009, In: Leukemia. 23, 2, p. 215-24 10 p.Research output: Contribution to journal › Article › peer-review